These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 16028511)
1. [Burkholderia cepacia under different ecological conditions: the amount and variability of the bacterial population]. Pushkareva VI; Velichko VV; Kaminskaia AA; Alekseeva NV; Litvin VIu Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):39-44. PubMed ID: 16028511 [TBL] [Abstract][Full Text] [Related]
2. [Experimental evaluation of interaction between Yersinia pestis and soil infusoria and possibility of prolonged preservation of bacteria in the protozoan oocysts]. Pushkareva VI Zh Mikrobiol Epidemiol Immunobiol; 2003; (4):40-4. PubMed ID: 12966875 [TBL] [Abstract][Full Text] [Related]
4. [Variability of the clonal structure of Yersinia pseudotuberculosis population under different conditions]. Pushkareva VI; Velichko VV; Solokhina LV; Litvin VIu Zh Mikrobiol Epidemiol Immunobiol; 2004; (4):31-5. PubMed ID: 15481916 [TBL] [Abstract][Full Text] [Related]
5. [Bacteria of the Burkholderia cepacia complex: specific features of diagnostics, genome organization and metabolism]. Shaginian IA; Chernukha MIu Mol Gen Mikrobiol Virusol; 2003; (2):3-10. PubMed ID: 12800768 [TBL] [Abstract][Full Text] [Related]
6. Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media. Vermis K; Vandamme PA; Nelis HJ J Appl Microbiol; 2003; 95(6):1191-9. PubMed ID: 14632991 [TBL] [Abstract][Full Text] [Related]
8. Production in vitro, on different solid culture media, of two distinct exopolysaccharides by a mucoid clinical strain of Burkholderia cepacia. Cérantola S; Montrozier H FEMS Microbiol Lett; 2001 Aug; 202(1):129-33. PubMed ID: 11506920 [TBL] [Abstract][Full Text] [Related]
9. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli. Clode FE; Kaufmann ME; Malnick H; Pitt TL J Clin Pathol; 1999 Mar; 52(3):173-6. PubMed ID: 10450174 [TBL] [Abstract][Full Text] [Related]
11. A novel strategy for the isolation and identification of environmental Burkholderia cepacia complex bacteria. Vanlaere E; Coenye T; Samyn E; Van den Plas C; Govan J; De Baets F; De Boeck K; Knoop C; Vandamme P FEMS Microbiol Lett; 2005 Aug; 249(2):303-7. PubMed ID: 16000240 [TBL] [Abstract][Full Text] [Related]
12. Immigration and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities. Al-Bakri AG; Gilbert P; Allison DG J Appl Microbiol; 2004; 96(3):455-63. PubMed ID: 14962125 [TBL] [Abstract][Full Text] [Related]
13. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Vandamme P; Holmes B; Vancanneyt M; Coenye T; Hoste B; Coopman R; Revets H; Lauwers S; Gillis M; Kersters K; Govan JR Int J Syst Bacteriol; 1997 Oct; 47(4):1188-200. PubMed ID: 9336927 [TBL] [Abstract][Full Text] [Related]
14. Generation of a reproducible nutrient-depleted biofilm of Escherichia coli and Burkholderia cepacia. Bühler T; Ballestero S; Desai M; Brown MR J Appl Microbiol; 1998 Sep; 85(3):457-62. PubMed ID: 9750276 [TBL] [Abstract][Full Text] [Related]
15. [Development of the controlled model of persisting infection , caused by Pseudomonas aeruginosa and bacteria of the complex Burkholderia cepacia]. Chernukha MIu; Kovtun VP; Nikolaeva TN; Shaginian IA; Gintsburg AL Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):14-20. PubMed ID: 15188552 [TBL] [Abstract][Full Text] [Related]